Stock Scorecard
Stock Summary for Upexi Inc (UPXI) - $0.49 as of 4/23/2024 1:55:07 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for UPXI
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for UPXI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for UPXI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for UPXI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for UPXI
Financial Details for UPXI
Company Overview |
|
|---|---|
| Ticker | UPXI |
| Company Name | Upexi Inc |
| Country | USA |
| Description | Grove, Inc., is engaged in the development, production, marketing, and sale of raw materials, private label products, and end-consumer products containing the industrial hemp plant extract, cannabidiol. The company is headquartered in Henderson, Nevada. |
| Sector Name | LIFE SCIENCES |
| Industry Name | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/15/2024 |
Stock Price History |
|
| Last Day Price | 0.49 |
| Last Day Price Updated | 4/23/2024 1:55:07 PM EST |
| Last Day Volume | 32,857 |
| Average Daily Volume | 36,026 |
| 52-Week High | 4.55 |
| 52-Week Low | 0.43 |
| Last Price to 52 Week Low | 13.95% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 13.72 |
| Sector PE | 60.50 |
| 5-Year Average PE | -12.76 |
| Free Cash Flow Ratio | 5.44 |
| Industry Free Cash Flow Ratio | 53.96 |
| Sector Free Cash Flow Ratio | 29.99 |
| Current Ratio Most Recent Quarter | 0.93 |
| Total Cash Per Share | 0.09 |
| Book Value Per Share Most Recent Quarter | 1.25 |
| Price to Book Ratio | 0.44 |
| Industry Price to Book Ratio | 2.22 |
| Sector Price to Book Ratio | 22.08 |
| Price to Sales Ratio Twelve Trailing Months | 0.12 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
| Total Shares Outstanding | 20,889,400 |
| Market Capitalization | 10,235,806 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 3,573.00% |
| Annual Earnings Growth | -754.84% |
| Reported EPS 12 Trailing Months | -1.13 |
| Reported EPS Past Year | -0.17 |
| Reported EPS Prior Year | -0.98 |
| Net Income Twelve Trailing Months | -24,624,971 |
| Net Income Past Year | -17,490,256 |
| Net Income Prior Year | -2,046,030 |
| Quarterly Revenue Growth YOY | -18.40% |
| 5-Year Revenue Growth | 82.98% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,844,420 |
| Total Cash Past Year | 4,492,291 |
| Total Cash Prior Year | 7,149,806 |
| Net Cash Position Most Recent Quarter | -6,792,974 |
| Net Cash Position Past Year | -23,253,601 |
| Long Term Debt Past Year | 27,745,892 |
| Long Term Debt Prior Year | 14,300,884 |
| Total Debt Most Recent Quarter | 8,637,394 |
| Equity to Debt Ratio Past Year | 0.50 |
| Equity to Debt Ratio Most Recent Quarter | 0.75 |
| Total Stockholder Equity Past Year | 27,836,623 |
| Total Stockholder Equity Prior Year | 28,786,744 |
| Total Stockholder Equity Most Recent Quarter | 25,462,661 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.04 |
| MACD Signal | -0.05 |
| 20-Day Bollinger Lower Band | 0.27 |
| 20-Day Bollinger Middle Band | 0.87 |
| 20-Day Bollinger Upper Band | 1.46 |
| Beta | 0.50 |
| RSI | 41.69 |
| 50-Day SMA | 1.59 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 4/23/2024 1:51:05 PM EST |